Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other financing activities (2017 - 2021)

Regenxbio has reported Other financing activities over the past 4 years, most recently at $128000.0 for Q2 2021.

  • Quarterly results put Other financing activities at $128000.0 for Q2 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $379000.0 (changed N/A YoY), and the annual figure for FY2021 was $379000.0, changed.
  • Other financing activities for Q2 2021 was $128000.0 at Regenxbio, down from $251000.0 in the prior quarter.
  • Over the last five years, Other financing activities for RGNX hit a ceiling of $251000.0 in Q1 2021 and a floor of $84000.0 in Q1 2017.
  • Median Other financing activities over the past 3 years was $146000.0 (2017), compared with a mean of $163500.0.